MedTrace Logo

Effect of EPA-DHA Supplement, Life Style Modification Standard Treatment on Clinical Outcome Lipid Membrane Composition in Type 2 Diabetes

NCT02705430 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-01-09

No results posted yet for this study

Summary

The aim of the present study is: to examine some of the mechanisms by which a change in life style alone or supplemented with a diet supplemented in n-3 PUFA, and associated with this computerized life style regulation reduces the development of diabetic complication in a small population based study.

(The NewMe™ / Eco-fusion, Ltd is a science-driven lifestyle change program for better living -www.eco-fusion.com)

Conditions

Interventions

DIETARY_SUPPLEMENT

EPA and DHA capsules of 2 g/day

EPA and DHA capsules of 2 g/day

BEHAVIORAL

Stress management phone application (Eco Fusion Mentally)

Stress management phone application (Eco Fusion Mentally)

BEHAVIORAL

life style program using a mobile phone (Eco Mentally and NewMe)

life style program using a mobile phone (Eco Mentally and NewMe)

DEVICE

mobile phone

mobile phone

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Pierre Singer, Professor · Head of General Intensive care unit

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02705430 on ClinicalTrials.gov